Net gamma exposure for Regeneron Pharmaceuticals Inc (REGN) options was positive at the Nov 4, 2026 close, about $16.94M per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for REGN, 2026-11-06(w), calls & puts
Gamma Exposure Stats
Showing results for REGN, 2026-11-06(w), calls & puts
Net Gamma Exposure by Expiration
Showing results for REGN, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
REGN Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is REGN gamma exposure positive or negative?
Regeneron Pharmaceuticals net gamma exposure was positive on Nov 4, 2026, at $16.94M. It has been positive on 20 of the last 20 trading days.
How has REGN gamma exposure changed recently?
Regeneron Pharmaceuticals net gamma exposure went from $6.13M on Oct 7, 2026 to $16.94M on Nov 4, 2026. See the REGN gamma exposure history for a longer view.
What is Regeneron Pharmaceuticals Inc?
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.